Outcome of patients with malignant hypertension and end-stage renal failure treated by long-term hemodialysis

Cardiology

Volumn 92, Issue 2, 1999, Pages 93-98

  De Lima, José Jayme Galvão ^a,b   Da Fonseca, João Américo ^b   Godoy, Anibal ^b   Bortolotto, Luis Aparecido ^a   Krieger, Eduardo M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Dialysis Center   (Brazil)

Author keywords

Hemodialysis; Hypertension, malignant; Renal failure, chronic

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MALE; MALIGNANT HYPERTENSION; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0033493483     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006954     Document Type: Article

References (15)

1. Isles CG, Lim KG, Boulton-Jones M, Cameron H, Lever AF, Murray G, Robertson JW: Factors influencing mortality in malignant hypertension. J Hypertens 1985;suppl 3:S405-S407.
2. Yu SH, Whitworth JA, Kincaid-Smith PS: Malignant hypertension: Aetiology and outcome in 83 patients. Clin Exp Hypertens [A] 1986;8: 1211-1230.
3. Guerrin C, Gonthier R, Berthoux FC: Long-term prognosis in malignant or accelerated hypertension. Nephrol Dial Transplant 1988;3: 33-37.
4. Lip GY, Beevers M, Beevers DG: Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995;3: 915-924.
5. Keith MN, Wagener HP, Barker NW: Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 1939;196: 332-339.
6. De Lima JJG, Abensur H, Bernardes-Silva H, Bellotti G, Pileggi F: Role of arterial hypertension in left ventricle hypertrophy in hemodialysis patients: An echocardiographic study. Cardiology 1992;80:161-167.
7. Kaplan EL, Meir P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
8. Patel R, Ansari A, Grim CE: Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. Am J Cardiol 1990;66:868-869.
9. Goldwasser P, Mittman N, Antignani A, Burrel D, Michel AM, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993;3:1613-1622.
10. US Renal Data System: USRDS 1997 Annual Data Report (July 1997). Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997, pp 69-89.
11. Valderrábano F, Jones EHP, Mallik NP: Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995; 10(suppl 5):1-25.
12. Lawton WJ: The short term course of renal function in malignant hypertensives with renal insufficiency. Clin Nephrol 1982;17:277-283.
13. Clough CG, Beevers DG, Beevers M: Survival of malignant hypertension in blacks, whites and Asians in Britain. J Hum Hypertens 1990; 4:94-96.
14. Gudbrandsson T, Hansson L, Herlitz H, Andren L: Malignant hypertension. Improving prognosis in a rare disease. Acta Med Scand 1979;206:495-499.
15. Gregory YH, Beevers M, Beevers G: The failure of malignant hypertension to decline: A survey of 24 years' experience in a multiracial population in England. J Hypertens 1994;12: 1297-1305.